结节性硬化症相关癫痫病理特点和致痫机制研究进展

doi:10.19854/j.cnki.1008-2425.2023.05.0011

摘要/Abstract

摘要： 结节硬化症相关性癫痫(TSC-related epilepsy,TRE)是结节硬化症神经系统表现之一,多数为难治性癫痫,其脑部病理学改变可能是癫痫发生的病理学基础,其发生机制复杂,目前尚未完全明确,临床治疗难度较大,深入了解结节硬化症患者脑部病理学改变及癫痫发生机制,对促进结节硬化症相关性癫痫临床治疗具有重要的意义,本文对结节硬化症脑部病理学及致痫机制进行综述,旨在为TRE的治疗提供理论参考。

关键词: 结节性硬化症, 癫痫, 致痫机制, 病理特征

中图分类号:

R742.1

崔浩然, 申强, 张军臣. 结节性硬化症相关癫痫病理特点和致痫机制研究进展[J]. 立体定向和功能性神经外科杂志, 2023, 36(5): 316-320.

参考文献

[1] Islam MP,Roach ES.Tuberous sclerosis complex[J].Handb Clin Neurol,2015,132:97~109.
[2] 丁平,关宇光,梁树立,等.结节性硬化症相关癫痫外科治疗中国专家共识[J].中国当代儿科杂志,2019,21(8):735~742.
[3] Liu S,Yu T,Guan Y,et al.Resective epilepsy surgery in tuberous sclerosis complex:a nationwide multicentre retrospective study from China[J].Brain,2020,143(2):570~581.
[4] Kannan L,Vogrin S,Bailey C et al.Centre of epileptogenic tubers generate and propagate seizuresintuberoussclerosis[J].Brain,2016,139,2653~2667.
[5] Kumari K,Sharma MC,Kakkar A,et al.mTOR pathway activation in focal cortical dysplasia[J].Annals of diagnostic pathology,2020,46:151523.
[6] 梁乐,冷慧,邢炜,等.结节性硬化症14例临床病理观察[J].中华病理学杂志,2016(2):102~106.
[7] Veersema TJ,de Neef A,van Scheppingen J,et al.Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development,focal cortical dysplasia or TSC-related cortical tubers[J].Int J Dev Neurosci,2019,79:96~104.
[8] Wong M.The role of glia in epilepsy,intellectual disability,and other neurodevelopmental disorders in tuberous sclerosis complex[J].J Neurodev Disord,2019,11(1):30.
[9] Curatolo P,Specchio N,Aronica E.Advances in the genetics and neuropathology of tuberous sclerosis complex:edging closer to targeted therapy[J].Lancet Neurol,2022,21(9):843~856.
[10] Gelot AB,Represa A.Progressionof fetal brain lesions in tuberous sclerosis complex[J].front Neurosci,2020,14:899.
[11] Zhang B,Zou J,Han L,et al.The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex[J].Epilepsia,2018,59(9):1796~1806.
[12] Alcover-Sanchez B,Garcia-Martin G,Wandosell F,et al.R-Ras GTPases signaling role in myelin neurodegenerative diseases[J].Int J Mol Sci,2020,21(16):5911.
[13] Tarkowski B,Kuchcinska K,Blazejczyk M,et al.Pathological mTOR mutations impact cortical development[J].Hum Mol Genet,2019,28(13):2107~2119.
[14] de Curtis M,Garbelli R,Uva L.A hypothesis for the role of axon demyelination in seizure generation[J].Epilepsia,2021,62(3):583~595.
[15] Mühlebner A,van Scheppingen J,de Neef A,et al.Myelin pathology beyond white matter in tuberous sclerosis complex (TSC) cortical tubers.J Neuropathol Exp Neurol,2020,79(10):1054~1064.
[16] Huang W,Bhaduri A,Velmeshev D,et al.Origins and proliferative states of human oligodendrocyte precursor cells[J].Cell,2020,182(3):594~608.
[17] Gruber VE,Lang J,Endmayr V,et al.Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies[J].Neuropathol Appl Neurobiol,2021,47(6):812~825.
[18] McLane LE,Bourne JN,Evangelou AV,et al.Loss of Tuberous sclerosis complex1 in adult oligodendrocyte progenitor cells enhances axon remyelination and increases myelin thickness after a focal demyelination[J].J Neurosci,2017,37(31):7534~7546.
[19] 耿明英,程远,许民辉.神经递质与癫痫的发病机制[J].立体定向和功能性神经外科杂志,2006,(3):188~192.
[20] Zhao JP,Yoshii A.Hyperexcitability of the local cortical circuit in mouse models of tuberous sclerosis complex[J].Mol Brain,2019,12(1):6.
[21] Boer K,Troost D,Timmermans W,et al.Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex[J].Neuroscience,2008,156(1):203~215.
[22] Kelly E,Schaeffer SM,Dhamne SC,et al.mGluR5 Modulation of behavioral and epileptic phenotypes in a mouse model of tuberous sclerosis complex[J].Neuropsychopharmacology,2018,43(6):1457~1465.
[23] Wong M,Crino PB.Tuberous sclerosis and epilepsy:role of astrocytes[J].Glia,2012,60(8):1244~1250.
[24] Koene LM,Niggl E,Wallaard I,et al.Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis[J].JCI Insight,2021,6(23):e150120.
[25] Hsieh LS,Wen JH,Nguyen LH,et al.Ectopic HCN4 expression drives mTOR-dependent epilepsy in mice[J].Sci Transl Med,2020,12(570):eabc1492.
[26] Wang LK,Chen X,Zhang CQ,et al.Elevated Expression of TRPC4 in cortical lesions of focal cortical dysplasia II and tuberous sclerosis complex[J].J Mol Neurosci, 2017,62(2):222~231.
[27] Hisatsune C,Shimada T,Miyamoto A,Lee A,Yamagata K.Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca²⁺ Influx via L-Type Ca²⁺ Channels[J].J Neurosci,2021,41(39):8134~8149.
[28] Mukhtar I.Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy:from pathogenesis to treatment target[J].Seizure,2020,82:65~79.
[29] Gruber VE,Luinenburg MJ,Colleselli K,et al.Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions[J].Epilepsia,2022,63(2):364~374.
[30] Nikolic L,Shen W,Nobili P,et al.Blocking TNFα-driven astrocyte purinergic signaling restores normal synaptic activity during epileptogenesis[J].Glia,2018,66(12):2673~2683.
[31] Leo A,Nesci V,Tallarico M,et al.IL-6 receptor blockade by tocilizumab has anti-absence and anti-epileptogenic effects in the WAG/Rij rat model of absence epilepsy[J].Neurotherapeutics,2020,17(4):2004~2014.
[32] Zhang S,Chen F,Zhai F,et al.Role of HMGB1/TLR4 and IL-1β/IL-1R1 signaling pathways in epilepsy[J].Front Neurol,2022,13:904225.